Given that the oxidative deamination of dopamine catalyzed by MAO-B generates hydrogen peroxide and aldehydes, easily leading to oxidative damage in nerve cells, irreversible MAO-B inhibitors such as selegiline and rasagiline have demonstrated antioxidant and neuroprotective properties in in vitro and in vivo PD models. The gene discussed is MAOB; the disease is Parkinson disease.